Prof.Wendy Stevens
Professor Wendy Stevens, MMed (Haem, Wits), FCPath (SA) (Haem, Wits)
Executive Director: Wits Diagnostic Innovation Hub
Strategic Director: National Priority Programs, NHLS
Director: ILEAD; Regional Innovation Hub
Prior Head: Department of Molecular Medicine and Haematology, Specialist Haematologist
H-index: Scopus – 57 / Google Scholar – 73 / ResearchGate - 65
Ranked 9 in microbiology in SA
Professor Stevens is a medical doctor, specialist pathologist by profession, who has made significant contributions to the development of capacity for affordable, accessible HIV and TB diagnosis and monitoring in South Africa and over 60 centers in sub-Saharan Africa. Her research activities have included expanding early infant diagnosis of HIV, making HIV viral load and CD4 testing more affordable, and investigating HIV drug resistance. In 2006, she was honored with an award from the National Department of Science and Technology for her contributions to the development of laboratory capacity in Southern Africa, and in 2023 received the SAMRC Gold Scientific Achievement Merit Award in recognition of the excellence of research.
Prof Stevens has served as an advisor to and investigator for various HIV research networks, including the International AIDS Vaccine Initiative (IAVI) in New York, the HIV Vaccine Trials Network (HVTN) in Seattle (NIH funded), the AIDS Clinical Trials Group (ACTG) (also NIH funded), the Microbicide Development Program (funded in the UK), and the ACTG Pharmacology Scientific Committee, among others. Additionally, she has held investigator status for several internationally funded projects, such as the CIPRA project in collaboration with Professor McIntyre and the team at the University of the Witwatersrand. Her research has received funding from various organizations including the Netherlands AIDS Fund, the Gates Foundation, Grand Challenges Canada, the Global Fund, PEPFAR, CDC, USAID, and the MRC. Prof Stevens has also served as a consultant for the World Health Organization in Geneva, the CDC in Atlanta, and the NIH in Bethesda, USA, on several different working groups. She participates in review committees for UNITAID (WHO) and the Bill and Melinda Gates Foundation Grand Challenges.
Since November 2010, Prof Stevens has held the role of Strategic Director of National Priority Programs at the National Health Laboratory Service, focusing on laboratory efforts related to priority diseases such as HIV, TB, and cervical cancer. Her current portfolio includes options for implementation at scale through the National Priority Programme and optimizing the clinic-laboratory chain through innovations for Africa via the African Innovation Network called iLEAD (three centres of excellence across South Africa, Mozambique and Senegal).
During the more recent SARs-CoV-2 outbreak, Prof Stevens and her team were responsible for national assay validation of over 256 assays, including molecular, serology, and antigen, antibody-based testing. Prof Stevens founded the Wits Diagnostic Innovation Hub in 2022, which encapsulates her foresight in bridging the gap between research and implementation science, aiming to foster innovation, and increasing the access to diagnostics to those that need it the most.
Wits DIH provides a platform for innovators, organisations, and vendors to evaluate and validate these technologies, as well as offer guidance on regulatory and implementation frameworks within a real-world setting.
The impact of Prof. Stevens's work is also evident in her significant contributions to the literature, with over 500 peer-reviewed manuscripts and book chapters, enriching the global knowledge base on molecular medicine haematology and infectious diseases.
Prof. Stevens's distinguished career is not just a series of achievements but a testament to her unwaivering dedication to improving healthcare through innovation, research, implementation science and strong leadership.
Her work has not only had a profound impact on the lives of patients in South Africa and beyond but also set a precedent for future generations in the healthcare and research communities. She recently received the SAMRC gold medal for her research.